⌘K

Login Start Free

Home/Filings/4/0001562180-25-005120

4//SEC Filing

Gengos Andrew 4

Accession 0001562180-25-005120

CIK 0001831363other

View on SEC.gov Company Profile

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 5:38 PM ET

Size

6.3 KB

Accession

0001562180-25-005120

Insider Transaction Report

Form 4

Period: 2025-06-27

Terns Pharmaceuticals, Inc.TERN

Chief Financial Officer

Transactions

Purchase
Common Stock
2025-06-27$3.93/sh+5,000$19,650→ 25,000 total
Purchase
Common Stock
2025-06-27$3.93/sh+5,000$19,634→ 20,000 total

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

Terns Pharmaceuticals, Inc.

CIK 0001831363

Entity typeother

Related Parties

1

filerCIK 0001563623

Filing Metadata

Form type: 4
Filed: Jun 29, 8:00 PM ET
Accepted: Jun 30, 5:38 PM ET
Size: 6.3 KB

View on SEC.gov